BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6748558)

  • 1. [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].
    Hiller E; Gerhartz H
    Klin Wochenschr; 1984 May; 62(10):441-5. PubMed ID: 6748558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison].
    Ell C; König HJ; Gutmann W; Domschke S; Domschke W
    Med Welt; 1983 Sep; 34(35):945-8. PubMed ID: 6355746
    [No Abstract]   [Full Text] [Related]  

  • 4. The control of cancer chemotherapy-induced nausea and vomiting.
    Dodds LJ
    J Clin Hosp Pharm; 1985 Jun; 10(2):143-66. PubMed ID: 2862166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
    Heim ME; Queisser W; Altenburg HP
    Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nausea and vomiting caused by cancer chemotherapy.
    Laszlo J
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():3-9. PubMed ID: 6299552
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of cancer chemotherapy-induced nausea and vomiting.
    Eyre HJ; Ward JH
    Cancer; 1984 Dec; 54(11 Suppl):2642-8. PubMed ID: 6498755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Wickham R
    Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chemotherapy-induced nausea and vomiting.
    Tortorice PV; O'Connell MB
    Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting].
    Kreutz S
    Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Ise T; Ohira M; Omiya A; Hirose M; Shibata T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum management of nausea and vomiting in cancer chemotherapy.
    Triozzi PL; Laszlo J
    Drugs; 1987 Jul; 34(1):136-49. PubMed ID: 3308410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New directions in managing chemotherapy-related emesis.
    Krasnow SH
    Oncology (Williston Park); 1991 Sep; 5(9 Suppl):19-24. PubMed ID: 1836346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
    Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
    Oncol Rep; 1998; 5(5):1147-55. PubMed ID: 9683826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.
    Glare P; Pereira G; Kristjanson LJ; Stockler M; Tattersall M
    Support Care Cancer; 2004 Jun; 12(6):432-40. PubMed ID: 15108099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
    Evers C; Riess H
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.